- Mosapride-Induced Movement Disorders
-
Hong SW, Shin HW
- KMID: 2533693
- J Mov Disord.
- 2022 Sep;15(3):273-276.
- doi: 10.14802/jmd.21149
-
- CITED
-
- Close
- SHARE
-
- Close
- Movement Disorders Resulting From Bilateral Basal Ganglia Lesions in End-Stage Kidney Disease: A Systematic Review
-
Yap KH, Baharudin NH, Gafor AHA, Remli R, Lim SY, Zaidi WAW, Azmin S, Mukari SAM, Khalid RA, Ibrahim NM
- KMID: 2533690
- J Mov Disord.
- 2022 Sep;15(3):258-263.
- doi: 10.14802/jmd.21185
Objective The basal ganglia (BG) are susceptible to fluctuations in blood urea levels, sometimes resulting in movement disorders. We described patients with end-stage kidney disease (ESKD) presenting with movement disorders... -
- CITED
-
- Close
- SHARE
-
- Close
- Catatonia in Hospitalized Patients With COVID-19: An Important Clinical Finding That Should Not be Missed
-
Ong TL, Sapuan S
- KMID: 2533694
- J Mov Disord.
- 2022 Sep;15(3):277-280.
- doi: 10.14802/jmd.21172
-
- CITED
-
- Close
- SHARE
-
- Close
- Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington’s Disease Presenting as Young Age-Onset Parkinsonism
-
Kim T, Choi BJ, Lyoo CH
- KMID: 2533699
- J Mov Disord.
- 2022 Sep;15(3):293-295.
- doi: 10.14802/jmd.22071
-
- CITED
-
- Close
- SHARE
-
- Close
- Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
-
Nishikawa N, Hatano T, Kamiyama D, Haginiwa-Hasegawa H, Oyama G, Hattori N
- KMID: 2533698
- J Mov Disord.
- 2022 Sep;15(3):290-292.
- doi: 10.14802/jmd.22021
-
- CITED
-
- Close
- SHARE
-
- Close
- Treatable Ataxias: How to Find the Needle in the Haystack?
-
Stezin A, Pal PK
- KMID: 2533685
- J Mov Disord.
- 2022 Sep;15(3):206-226.
- doi: 10.14802/jmd.22069
Treatable ataxias are a group of ataxic disorders with specific treatments. These disorders include genetic and metabolic disorders, immune-mediated ataxic disorders, and ataxic disorders associated with infectious and parainfectious etiology,... -
- CITED
-
- Close
- SHARE
-
- Close
- Blacksmith’s Dystonia Is Another Task-Specific Dystonia: From Past to Present
-
Kim MS, Park DG, Yoon JH
- KMID: 2533696
- J Mov Disord.
- 2022 Sep;15(3):284-285.
- doi: 10.14802/jmd.22037
-
- CITED
-
- Close
- SHARE
-
- Close
- Teaching Research Methods to Young Neurologists: The Erice International Courses
-
Rocca WA, Ragonese P, D'Ameilo M, Savettieri G
- KMID: 2533686
- J Mov Disord.
- 2022 Sep;15(3):227-231.
- doi: 10.14802/jmd.22130
-
- CITED
-
- Close
- SHARE
-
- Close
- Refractory Myoclonus as a Presentation of Metabolic Stroke in A Child With Cobalamin B Methylmalonic Acidemia After Liver and Kidney Transplant
-
Olson V, Chang IJ, Merritt 2nd JL, Mingbunjerdsuk D
- KMID: 2533695
- J Mov Disord.
- 2022 Sep;15(3):281-283.
- doi: 10.14802/jmd.21196
-
- CITED
-
- Close
- SHARE
-
- Close
- Multiple Sclerosis-Related Paroxysmal Kinesigenic Dyskinesia: Long Term, Favorable Response to Lacosamide
-
Poulidou V, Spilioti M, Moschou M, Papanikolaou N, Drevelegas A, Papagiannopoulos S, Kazis D, Kimiskidis VK
- KMID: 2533697
- J Mov Disord.
- 2022 Sep;15(3):286-289.
- doi: 10.14802/jmd.22016
-
- CITED
-
- Close
- SHARE
-
- Close
- Sensitivity of Detecting Alpha-Synuclein Accumulation in the Gastrointestinal Tract and Tissue Volume Examined
-
Shin C, Kim SI, Park SH, Shin JH, Lee CY, Yang HK, Lee HJ, Kong SH, Suh YS, Kim HJ, Jeon B
- KMID: 2533691
- J Mov Disord.
- 2022 Sep;15(3):264-268.
- doi: 10.14802/jmd.22042
Objective This study aimed to evaluate whether a larger tissue volume increases the sensitivity of detecting alpha-synuclein (AS) pathology in the gastrointestinal (GI) tract. Methods Nine patients with Parkinson’s disease (PD)... -
- CITED
-
- Close
- SHARE
-
- Close
- Nearly Abolished Dopamine Transporter Uptake in a Patient With a Novel FBXO7 Mutation
-
Kim EY, Kim SY, Seo Y, Shin C
- KMID: 2533692
- J Mov Disord.
- 2022 Sep;15(3):269-272.
- doi: 10.14802/jmd.22006
Mutations in the F-box only protein 7 (FBXO7) gene are the cause of autosomal recessive parkinsonian-pyramidal syndrome. Herein, we report a patient with a novel FBXO7 mutation with a unique... -
- CITED
-
- Close
- SHARE
-
- Close
- Pallidus Stimulation for Chorea-Acanthocytosis: A Systematic Review and Meta-Analysis of Individual Data
-
He W, Li C, Dong H, Shao L, Yin B, Li D, Ye L, Hu P, Zhang C, Yi W
- KMID: 2533684
- J Mov Disord.
- 2022 Sep;15(3):197-205.
- doi: 10.14802/jmd.22003
A significant proportion of patients with chorea-acanthocytosis (ChAc) fail to respond to standard therapies. Recent evidence suggests that globus pallidus internus (GPi) deep brain stimulation (DBS) is a promising treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Semiautomated Algorithm for the Diagnosis of Multiple System Atrophy With Predominant Parkinsonism
-
Lee WW, Kim HJ, Lee HJ, Kim HB, Park KS, Sohn CH, Jeon B
- KMID: 2533687
- J Mov Disord.
- 2022 Sep;15(3):232-240.
- doi: 10.14802/jmd.21178
Objective Putaminal iron deposition is an important feature that helps differentiate multiple system atrophy with predominant parkinsonism (MSA-p) from Parkinson’s disease (PD). Most previous studies used visual inspection or quantitative... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Link Between Cognition and Motor Reserve in Patients With Parkinson’s Disease
-
Chung SJ, Kim YJ, Kim YJ, Lee HS, Yun M, Lee PH, Jeong Y, Sohn YH
- KMID: 2533689
- J Mov Disord.
- 2022 Sep;15(3):249-257.
- doi: 10.14802/jmd.22063
Objective To investigate whether there is a link between cognitive function and motor reserve (i.e., individual capacity to cope with nigrostriatal dopamine depletion) in patients with newly diagnosed Parkinson’s disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia
-
Woo KA, Kim HJ, Jeon SH, Park HR, Park KW, Lee SH, Chung SJ, Chae JH, Paek SH, Jeon B
- KMID: 2533688
- J Mov Disord.
- 2022 Sep;15(3):241-248.
- doi: 10.14802/jmd.22002
Objective To investigate the long-term clinical outcomes of pallidal deep brain stimulation (GPi-DBS) in patients with pantothenate kinase-associated neurodegeneration (PKAN). Methods We reviewed the records of patients with genetically confirmed PKAN... -
- CITED
-
- Close
- SHARE
-
- Close
